Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade

Cell Reports(2022)10.1016/j.celrep.2022.110582Source: DataRank Database

PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Download PDF

Cite:

Linked data & code

geo hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 4.08)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Oscar D. Villarreal ORCID,Swanand Hardikar,Zhenbao Yu ORCID,Samuel E.J. Preston ORCID,Wilson H. Miller ORCID

Live enrichment

PubMed:35354055 PMC:PMC9838175 OpenAlex:https://openalex.org/W4225394279

McGill University

Grant: FDN-154303

McGill University

Grant: PJT-162260

National Institutes of Health

Grant: R01AI1214030A1

NIAID NIH HHS

Grant: R01 AI121403

NIGMS NIH HHS

Grant: R35 GM137927

Canadian Institutes of Health Research

Foundation for the National Institutes of Health

Harvard Medical School

Fonds de Recherche du Québec - Santé

FWCI

4.08

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124722003266/pdf

publisherhttp://www.cell.com/article/S2211124722003266/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722003266?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722003266?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2022.110582

Fields of Study

Cancer-related gene regulationCAR-T cell therapy researchImmune Cell Function and InteractionAnimalsEndogenous RetrovirusesImmune Checkpoint InhibitorsInterferonsMelanoma, ExperimentalNeoplasm Recurrence, Local

MeSH Terms

Immune Checkpoint InhibitorsAnimalsInterferonsMelanoma, ExperimentalNeoplasm Recurrence, LocalEndogenous Retroviruses

Keywords

Cancer researchBiologyImmune checkpointImmune systemMelanomaImmunityImmunotherapyImmunologydsRNADnmtsArginine MethylationImmune Checkpoint InhibitorsPrmt7Rlr PathwayCytotoxic T cellsCp: ImmunologyCp: Cancer

Sustainable Development Goals

SDG 0: Good health and well-being

PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade

FAIR Checklist

Authors (12)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)